Medication info
Simvastatin/Ezetimibe Tablet 10/10

Simvastatin/Ezetimibe Tablet 10/10

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
White to light yellow, double convex, rectangular tablet
Packaging
30 tablets (10 tablets PTP packaging x 3)
Approval status
Active

MFDS item code 201601716 · Approved 2016.03.31 · Insurance code 649103020

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This drug helps to lower total cholesterol, LDL cholesterol, ApoB, and triglyceride levels, and to raise HDL cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia when used in conjunction with a dietary regimen. In particular, it can be used in conjunction with or as an alternative therapy for patients with homozygous familial hypercholesterolemia. This drug is used as an adjunct when dietary measures and other non-drug interventions, which limit saturated fat and cholesterol intake, are ineffective without relying solely on medications. It is important to identify and manage other causes of hypercholesterolemia, such as diabetes and hypothyroidism, before administration, and to routinely check and manage total cholesterol, LDL, HDL, and triglyceride levels during treatment. This drug is effectively used to reduce the risk of hypercholesterolemia and related atherosclerotic vascular diseases.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This drug is primarily used to lower blood cholesterol levels. However, serious muscle-related side effects such as myopathy or rhabdomyolysis may occur while taking this medication, so caution is advised. The risk may be higher when taken in high doses or in conjunction with certain other medications. This drug should not be administered to patients with poor liver function, pregnant women, or nursing mothers. Special monitoring is necessary when this drug is used in patients with liver dysfunction or a history of liver disease. If severe muscle weakness symptoms appear, consult a physician immediately and discontinue use of the drug. This drug can interact with several other medications, so it is essential to inform healthcare professionals of any other medications being taken. In particular, combining with certain antibiotics, antifungals, immunosuppressants, and some heart medications can increase the risk of muscle damage. If symptoms such as muscle pain, muscle weakness, or severe fatigue occur during use, notify a healthcare facility immediately. Use in the elderly or children requires caution, and for children, consultation with a specialist is advised before use. Additionally, this drug may affect blood glucose levels, so regular blood glucose testing is recommended for patients at risk of diabetes. Regular liver function tests and muscle-related examinations during treatment are safe. There is no specific antidote for overdose, so immediate medical attention is required for appropriate treatment. Finally, women who plan to become pregnant or are pregnant should not use this medication, and it should be discontinued immediately if pregnancy is confirmed.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, nausea, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, vomiting, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction with systemic symptoms, erythema multiforme, drug-induced liver injury, weakness, cataract, constipation, dyspepsia, flatulence, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disturbance, oculomotor dysfunction, facial partial paralysis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory impairment, forgetfulness, amnesia, memory dysfunction, confusion, severe muscle weakness, ocular muscle weakness, interstitial lung disease, angioedema, lupus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, fatigue, dyspnea, pancreatitis, hepatitis, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, eye muscle paralysis, anemia, elevated aminotransferases, elevated ALP, increased ɤ-GT, elevated bilirubin levels, thyroid dysfunction, increased serum creatine kinase, transient liver function test abnormalities, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air and moisture. The appropriate storage temperature is room temperature between 1 and 30 degrees Celsius, and it is advisable to avoid excessively hot or cold locations.

Appearance and packaging

Appearance

White to light yellow, double convex, rectangular tablet

Package unit

30 tablets (10 tablets PTP packaging x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.